Top Pfizer scientist on COVID-19 vaccine

Pfizer announced it will supply 200 million doses of its COVID-19 vaccine for the U.S. by the end of May and is aiming to ship 2 billion doses globally this year. The vaccine is over 90% effective according to clinical trials conducted in 2020, but more testing needs to be done to see how well it protects against the new variants. Dr. Phil Dormitzer, who helped develop the vaccine as vice president and chief scientific officer of viral vaccines at Pfizer, joins CBSN to discuss.

• Feb 9, 2021
• 08:23

Doctors urge pregnant women to get vaccinated

Health experts are saying it is important that pregnant women and women expecting to be pregnant receive COVID-19 vaccines. Dr. Frank Chervenak, chair of Obstetrics and Gynecology at Lenox Hospital in New York City, joins CBSN's Elaine Quijano to discuss.

• Feb 8, 2021
• 06:07

Facebook widens ban on vaccine misinformation

The platform added a new set of false claims to its list of COVID-19 information that will be removed.

• Feb 8, 2021

Biden's $1.9 trillion COVID relief plan

President-elect Joe Biden released a comprehensive economic relief bill to help the country dig out of the hard times brought on by the pandemic. CBS News White House correspondent Weijia Jiang joins CBSN's Tanya Rivero to discuss what's in the bill and when it could pass.

• Jan 15, 2021
• 08:37

COVID cases and hospitalizations decline in U.S.

The fight against the coronavirus is gaining momentum in the U.S. as hospitalizations and infections continue to fall. As CBS News' Meg Oliver reports, health experts warn the U.S. not out of the woods yet as variants emerge and the Super Bowl threatens to be the next super-spreader event. Dr. Dara Kass, an ER doctor and medical contributor for Yahoo News, joins CBSN's Elaine Quijano with the latest developments on the pandemic.

• Feb 8, 2021
• 09:33

Online scams target Americans seeking vaccine

Law enforcement is warning of a growing number of online scams tied to COVID vaccinations. Scammers are now claiming to have vaccines for sale. Manuel Bojorquez takes a look.

• Feb 8, 2021
• 01:51

U.S. races to administer vaccines as variant threat grows stronger

A new, more contagious variant of the virus may soon become the dominant strain.

• Feb 8, 2021

COVID vaccines and concern about variants

South Africa is putting a pause on its rollout of the Oxford-AstraZeneca vaccine after a study there found it was not effective against the variant dominant in the country. Physician and immunotherapy scientist Dr. Leo Nissola joins CBSN to discuss the latest research and the danger as new variants continue to evolve.

• Feb 8, 2021
• 05:35

Variants raise concerns that people can get COVID-19 again

Even in cases where reinfection causes no symptoms or just mild ones, people might still spread the virus.

• Feb 8, 2021

U.K. doctor helps build confidence in vaccine

As COVID-19 inoculation efforts are underway, some people remain hesitant. But these health care workers are doing their best to combat false information and protect their communities. Dr. Nighat Arif shares her story with our partners at BBC News.

• Feb 8, 2021
• 04:36

Expert on COVID-19 vaccine developments

Vaccination efforts around the world are picking up steam. Meanwhile, Pfizer announced it expects to cut production time for its COVID-19 vaccine by nearly 50%. CBS News senior foreign correspondent Elizabeth Palmer has an update on the worldwide effort, and David Montefiori, a professor and director of Duke University's Laboratory for AIDS Vaccine Research and Development, joins CBSN's Lana Zak to discuss.

• Feb 7, 2021
• 10:40

Concerns about COVID variant in South Africa

Government leaders in South Africa are halting the rollout of 1 million doses of the Oxford-AstraZeneca vaccine after new research indicates it may not work against a COVID-19 variant that's now prevalent in the country. CBS News foreign correspondent Debora Patta joins CBSN from Johannesburg with more .

• Feb 8, 2021
• 06:50

Impeachment could threaten stimulus talks

The second Senate impeachment trial of former President Donald Trump is set to begin tomorrow on Capitol Hill. This comes as President Joe Biden urges Congress to pass his $1.9 trillion COVID-19 relief package. CBS News Capitol Hill producer Rebecca Kaplan joins CBSN to explain the latest developments.

• Feb 8, 2021
• 11:18

Beware bogus COVID vaccine offers proliferating on the "dark web"

The space has added the phony vaccines to its offers of fake PPE, COVID tests and cures, warns CBS Chicago.

• Feb 8, 2021

Top WHO official: Vaccines alone "not enough"

Dr. Maria Van Kerkhove, the World Health Organization's technical lead for COVID-19, says vaccination is "critical" but "not enough" to fully defeat the virus.

• Feb 7, 2021
• 07:26

A championship like no other: Super Bowl LV during COVID-19

James Brown, CBS News Special correspondent and host of "The Super Bowl Today," walks through the challenges of hosting one of the world's largest sporting events during a health crisis.

• Feb 7, 2021
• 06:07

Gottlieb says vaccines should offer "reasonable protection" from variants

Gottlieb said it can be assumed the vaccines are going to be roughly 20% less effective against the new strains from Brazil and South Africa.

• Feb 7, 2021

Mass vaccinations: How stadiums host a COVID defensive play

Although vaccines against the coronavirus have been developed in record time, the lack of a playbook on how to administer them quickly prompted a union between health workers and professional sports teams, to offer shots at stadiums and ball parks across the country. NPR's Allison Aubrey looks at how teams like the New England Patriots are taking the field against COVID.

• Feb 7, 2021
• 05:47

FDA considers Johnson & Johnson vaccine

The Biden administration is ramping up efforts to distribute and administer coronavirus vaccinations. Meanwhile, the FDA considers whether to give Johnson & Johnson's COVID-19 vaccine emergency use approval. Jodie Guest, a professor and Emory University's Department of Epidemiology vice chair, speaks to CBSN's Lana Zak about how it could be a game-changer in the fight against COVID-19.

• Feb 6, 2021
• 07:44

Super Bowl to honor frontline workers

The NFL will kick off the Super Bowl LV celebrations with a tribute to the nation's healthcare heroes. The league selected 7,500 vaccinated frontline workers from across the United States and awarded them free tickets to the big game. Married couple Dr. Andrea Buras, a gynecologic oncologist, and Dr. Ryan Kenney, an emergency medicine physician, spoke with Lana Zak about the significance of going to the game.

• Feb 6, 2021
• 08:03

Rural parts of Virginia lack access to COVID-19 vaccine

Mobile health care workers in rural Virginia are questioning the lack of coronavirus vaccines provided to poor and health-vulnerable communities.

• Feb 6, 2021

Watch From Home? COVID-19 and the Super Bowl

Playing it safe: CBS New medical contributor Dr. David Agus joins "CBS This Morning: Saturday" to discuss if Super Bowl parties can be superspreader events and the latest with vaccines.

• Feb 6, 2021
• 02:42

New COVID-19 vaccination megasites open

The Pentagon is sending more than 1,000 active-duty troops to the frontlines of vaccine distribution in the United States. Some will assist the vaccination effort at new COVID-19 vaccination megasites opening up across the country in places like casinos and baseball stadiums. Michael George reports.

• Feb 6, 2021
• 02:56

Experts urge staying home during the Super Bowl

With just two days until the big game, there are concerns that the Super Bowl could become a super-spreader event -- at home and in the stadium. Jamie Yuccas reports.

• Feb 5, 2021
• 02:58

11/30: Red and Blue

Moderna applies for emergency use authorization; White House decorated for the 2020 holidays

• Nov 30, 2020
• 49:51

Show More